Drugs To Undergo Clinical Trial Among Patients With Multiple Brain Tumors, With Hopes That They Could Treat and Shrink the Growth

Medicine & Technology Jun 23, 2024

The drug could possibly be used for treating neurofibromatosis 2 (NF2) tumors. Read to learn more.

HIV Vaccine Candidate Triggers Essential Antibodies in Humans, Shows Early Success in Clinical Trial

May 22, 2024

A new HIV vaccine triggered low levels of a rare type of neutralizing antibodies among a small group of people who participated in a 2019 clinical trial. Find out more about it in this article.

Novel Skin Cancer Vaccine Clinical Trial Shows Promising Results As Initial Data Reveals Recurrence, Death Risk Cut By 49%

Jan 05, 2024

When combined with KEYTRUDA, the skin cancer vaccine was observed to demonstrate promising results. Read to learn more.

Triple-Negative Breast Cancer Vaccine Shows Promising Results During Clinical Trial

Dec 18, 2023

A new treatment for aggressive triple-negative breast cancer could be on the way after a promising result was observed in a clinical trial.

First Human Trials for Cancer Pill as Potential Cure for Epilepsy To Begin in Australia in October

Mar 20, 2023

A pill for cancer will be tested for the first time as a cure for epilepsy in October. Read the article for more details.

Medical Breakthrough: Vaccine Trial Prolonged Life to Even Those With Aggressive Brain Cancer

Nov 18, 2022

Results of a clinical trial showed that the vaccine could prolong the life of cancer patients diagnosed with even the most aggressive glioblastoma. Check out this article to learn more details.

Groundbreaking Cancer Vaccine Made From Patient's Tumor Produced Hopeful Clinical Trial Results

Jul 04, 2022

The personalized cancer vaccine uses similar technology to the COVID-19 vaccine of Oxford-AstraZeneca to train the immune system for cancer cells. Check out how promising the critical trial results are.

New Pill for Alopecia-Related Hair Loss Approved by FDA

Jun 15, 2022

The Food and Drug Administration recently approved the first-ever drug against alopecia. Read more about the treatment and how it works.

Human Testing of Cancer-Killing Viral Drug Yielded Promising Results in Phase 1 Clinical Trials

May 24, 2022

The first phase of clinical trials over an anticancer solution showed efficacy when administered to human subjects. Read more about the experiments of the new cancer solution and how it works.

Comprehensive Study Shows Transparent Outcomes of Postprocedure Drugs Related to First-Generation Watchman Operations

May 04, 2022

A series of papers recently released showed a comprehensive outcome from widescale trials and procedures related to first-generation Watchman device. Read more about the effects of these operations, as well as the impact of postprocedure medications.

Japanese COVID-19 Pill Claims Rapid Vanishing of Coronavirus Infection

Apr 25, 2022

Shionogi & Co., a Japanese drugmaker said the use of its COVID pill causes the rapid clearance of coronavirus infection. Read on and learn more about it.

Novavax COVID-Flu Vaccine Shows Positive Results from Initial Trials; Formulation ‘Safe with Mostly Mild Side Effects’

Apr 21, 2022

Novavax announced its COVID-Flu vaccine is seen positive results from the phase I trials. Learn more about the efficacy of the vaccine and what lies ahead.

Male Contraceptive Pill Shows 99% Effectiveness in Laboratory Tests; Will Enter Human Trials in 2022

Mar 28, 2022

Clinical trials of a new male contraceptive pill are 99% effective. Find out how this male birth control pill differs from the female contraceptive.

Ivermectin Not A Miracle COVID-19 Drug: New Study Shows It Does Not Prevent Hospitalization for Severe Illness

Feb 21, 2022

A new Malaysian study that tested Ivermectin drug on 490 vulnerable patients over 50 years old showed no significant difference in preventing severe illness, casting doubts on its effectiveness against COVID-19.

Moderna Announces Clinical Trial for 3rd Vaccine Developed Against Omicron Variant

Jan 28, 2022

COVID-19 vaccine maker Moderna recently announced its first participant in a clinical trial has already been given its Omicron-specific vaccine.